Skip to content
NHLS WCA Number: 990000306648
  • Login to:
    • Thusano Portal
    • Proficiency Testing
    • Lab Results
    • WEB PTS Registration
    • CDW MicroStrategy
    • CSA
  • Staff Email
  • Contact Us
National Health Laboratory Service Logo National Health Laboratory Service Logo
  • Home
  • About Us
    • Overview
    • Board of Directors
    • Executive Management
    • Area Managers
    • Institutes & Subsidiaries
    • Laboratories
    • NHLS Achievements
    • Terms of Use
  • Our Services
    • Diagnostic
      • Type Of Tests
      • Diagnostic Media Products
      • Paternity Testing
      • MIC Testing
    • Academic Affairs and Research
      • Scope of Research
      • NHLS Research Trust
    • Training
    • Quality Assurance
      • Health Technology Assessment Unit
        • 2012-2021
        • 2022
        • 2023
        • 2024
        • 2025
      • Proficiency Testing
  • Priority Programmes
    • CD4
    • HIV Genotyping
    • HIV Viral Load
    • TB GeneXpert
    • Early Infant Diagnosis
  • Supply Chain
    • Latest RFQs
    • Latest Tender
    • Received Bids
    • Awarded Bids
    • Bid Cancellations
    • Bid Withdrawal
    • Awarded RFQ’s
    • RFQ Withdrawal
    • RFQ Cancellations
    • Archive
  • Key Documents
    • Annual Reports
    • Strategic Documents
    • paia
    • Acts and Bills
  • Media
    • Media Statements
    • NHLS in the News
    • Videos
    • Contact Us
  • Careers
    • Vacancies

testing

  1. Home
  2. testing
testing
Content Specialist2022-05-11T15:23:07+02:00

Immunoglobulin subtyping and quantification in direct antiglobulin test: positive haemolysis in an HIV-prevalent setting

Content Specialist2022-05-11T15:23:07+02:00May 9th, 2022|0 Comments

Chetty T, Bouwer N, Wan YO, Mahlangu J. Immunoglobulin subtyping and quantification in direct antiglobulin test: positive haemolysis in an HIV-prevalent setting. J Clin Pathol. 2022;75(2):117-20.


Content Specialist2022-05-11T15:23:33+02:00

DNA-Dependent Binding of Nargenicin to DnaE1 Inhibits Replication in Mycobacterium tuberculosis

Content Specialist2022-05-11T15:23:33+02:00May 9th, 2022|0 Comments

Chengalroyen MD, Mason MK, Borsellini A, Tassoni R, Abrahams GL, Lynch S, et al. DNA-Dependent Binding of Nargenicin to DnaE1 Inhibits Replication in Mycobacterium tuberculosis. ACS Infect Dis. 2022;8(3):612-25.


Content Specialist2022-05-11T15:23:57+02:00

Therapeutic Approaches to Amyotrophic Lateral Sclerosis from the Lab to the Clinic

Content Specialist2022-05-11T15:23:57+02:00May 9th, 2022|0 Comments

Chavda V, Patel C, Modh D, Ertas YN, Sonak SS, Munshi NK, et al. Therapeutic Approaches to Amyotrophic Lateral Sclerosis from the Lab to the Clinic. Curr Drug Metab. 2022.


Content Specialist2022-05-11T15:24:18+02:00

SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape

Content Specialist2022-05-11T15:24:18+02:00May 9th, 2022|0 Comments

Cele S, Karim F, Lustig G, San JE, Hermanus T, Tegally H, et al. SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape. Cell Host Microbe. 2022;30(2):154-62.e5.


Content Specialist2022-05-11T15:24:39+02:00

Trends in Diagnosis of Noninvasive Follicular Thyroid Neoplasm With Papillarylike Nuclear Features and Total Thyroidectomies for Patients With Papillary Thyroid Neoplasms

Content Specialist2022-05-11T15:24:39+02:00May 9th, 2022|0 Comments

Caulley L, Eskander A, Yang W, Auh E, Cairncross L, Cho NL, et al. Trends in Diagnosis of Noninvasive Follicular Thyroid Neoplasm With Papillarylike Nuclear Features and Total Thyroidectomies for Patients With Papillary Thyroid Neoplasms. JAMA Otolaryngol Head Neck Surg. 2022;148(2):99-106.


Content Specialist2022-05-11T15:25:01+02:00

Retrospective analysis to describe trends in first-ever prostate-specific antigen (PSA) testing for primary healthcare facilities in the Gauteng Province, South Africa, between 2006 and 2016

Content Specialist2022-05-11T15:25:01+02:00May 9th, 2022|0 Comments

Cassim N, Rebbeck TR, Glencross DK, George JA. Retrospective analysis to describe trends in first-ever prostate-specific antigen (PSA) testing for primary healthcare facilities in the Gauteng Province, South Africa, between 2006 and 2016. BMJ Open. 2022;12(3):e050646.


Previous272829Next
Content Specialist2022-06-06T11:11:46+02:00June 6th, 2022|

Share This Post, Choose Your Platform!

FacebookXRedditLinkedInWhatsAppTelegramTumblrPinterestVkXingEmail

Related Posts

Binocular Microscopes Incl 5 Year SLA – Tyg Hist E

Binocular Microscopes Incl 5 Year SLA – Tyg Hist E

Supply And Delivery Of A Fluke Probe Thermometer At NHLS Moses Kotane Laboratory

Supply And Delivery Of A Fluke Probe Thermometer At NHLS Moses Kotane Laboratory

Placement Of Chemistry And Immunoassay Analysers KZN Large And Medium Labs Including Service And Maintenance, And Reagent Deal For A Period Of Five (5) Years

Placement Of Chemistry And Immunoassay Analysers KZN Large And Medium Labs Including Service And Maintenance, And Reagent Deal For A Period Of Five (5) Years

Real-Time PCR Instrument, At NICD Sandringham, Johannesburg

Real-Time PCR Instrument, At NICD Sandringham, Johannesburg

South-to-south mentoring as a vehicle for implementing sustainable health security in Africa

South-to-south mentoring as a vehicle for implementing sustainable health security in Africa

REPORT FRAUD & CORRUPTION

Toll Free Number: 0800 000 552

SMS : 30916 (rates @ R1.50)
Email : nhls@thehotline.co.za
Free Fax : 086 726 1681

QUICK LINKS

National Biobank
SAVP
NICD
NIOH

SOCIAL MEDIA

NHLS

NICD

NIOH

PathReD

HEAD OFFICE

1 Modderfontein Road, Sandringham
Johannesburg, South Africa

Tel: 011-386-6000
Email: enquiries@nhls.ac.za
©2023 NHLS. All Rights Reserved. | Disclaimer | Terms of Use
Page load link
Go to Top